Cihan Uslu1, Mustafa Tüz1, Hasan Yasan1, Erdoğan Okur1. 1. Department of Otorhinolaryngology-Head and Neck Surgery, Süleyman Demirel University School of Medicine, Isparta, Turkey.
Abstract
OBJECTIVE: We aimed to investigate the association of the frequency of three single-nucleotide polymorphisms [glucose transporter isoform 1 (GLUT1) reference single-nucleotide polymorphism (rs) 710218, hypoxia-inducible factor 1 alpha (HIF1α) rs11549465, and T-box transcription factor protein 21 (TBX21) rs17250932], which have been proved to be related with various benign and malignant diseases, with the development of laryngeal cancer and its size and grade. METHODS: In this study, we included 35 patients with laryngeal cancer and 35 volunteers at least 30 years old who had smoked for at least 20 years. DNA was obtained from the blood samples of the participants using an isolation kit. Then, polymorphisms for both the groups were determined using real-time polymerase chain reaction. RESULTS: No significant differences were detected regarding the genotype and allele frequencies in the three polymorphisms assessed between the two groups. In the patient group, on examining the association of polymorphisms with tumor size and grade, no significant relation was observed in three polymorphisms regarding the related parameters. CONCLUSION: GLUT1, HIF1α, and TBX21 polymorphisms have no impact on the development of laryngeal cancer.
OBJECTIVE: We aimed to investigate the association of the frequency of three single-nucleotide polymorphisms [glucose transporter isoform 1 (GLUT1) reference single-nucleotide polymorphism (rs) 710218, hypoxia-inducible factor 1 alpha (HIF1α) rs11549465, and T-box transcription factor protein 21 (TBX21) rs17250932], which have been proved to be related with various benign and malignant diseases, with the development of laryngeal cancer and its size and grade. METHODS: In this study, we included 35 patients with laryngeal cancer and 35 volunteers at least 30 years old who had smoked for at least 20 years. DNA was obtained from the blood samples of the participants using an isolation kit. Then, polymorphisms for both the groups were determined using real-time polymerase chain reaction. RESULTS: No significant differences were detected regarding the genotype and allele frequencies in the three polymorphisms assessed between the two groups. In the patient group, on examining the association of polymorphisms with tumor size and grade, no significant relation was observed in three polymorphisms regarding the related parameters. CONCLUSION: GLUT1, HIF1α, and TBX21 polymorphisms have no impact on the development of laryngeal cancer.
Authors: Oxana Shangina; Paul Brennan; Neonila Szeszenia-Dabrowska; Dana Mates; Eleonóra Fabiánová; Tony Fletcher; Andrea t'Mannetje; Paolo Boffetta; David Zaridze Journal: Am J Epidemiol Date: 2006-06-26 Impact factor: 4.897
Authors: G Aynali; M Doğan; R Sütcü; O Yüksel; M Yariktaş; F Unal; H Yasan; B Ceyhan; M Tüz Journal: J Laryngol Otol Date: 2013-09-30 Impact factor: 1.469
Authors: P H Andraweera; G A Dekker; S D Thompson; V H W Dissanayake; R W Jayasekara; C T Roberts Journal: Placenta Date: 2014-05-02 Impact factor: 3.481
Authors: F Mera-Menéndez; A Hinojar-Gutiérrez; M Guijarro Rojas; J García de Gregorio; E Mera-Menéndez; J J Sánchez; M Quintanilla; L Cerezo; C Gamallo Journal: Clin Transl Oncol Date: 2012-08-23 Impact factor: 3.405
Authors: J Wipff; P Dieude; J Avouac; K Tiev; E Hachulla; B Granel; E Diot; J Sibilia; L Mouthon; O Meyer; A Kahan; C Boileau; Y Allanore Journal: Scand J Rheumatol Date: 2009 Impact factor: 3.641
Authors: Geza Nagy; Reka Kovacs-Nagy; Eva Kereszturi; Aniko Somogyi; Anna Szekely; Nora Nemeth; Nora Hosszufalusi; Pal Panczel; Zsolt Ronai; Maria Sasvari-Szekely Journal: BMC Med Genet Date: 2009-08-19 Impact factor: 2.103
Authors: Mirosław Śnit; Maciej Misiołek; Wojciech Ścierski; Anna Koniewska; Grażyna Stryjewska-Makuch; Sławomir Okła; Władysław Grzeszczak Journal: Int J Environ Res Public Health Date: 2021-07-13 Impact factor: 3.390